tiprankstipranks
BICO Group AB Class B (CLLKF)
OTHER OTC:CLLKF

BICO Group AB Class B Stock Analysis & Ratings

CLLKF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$7.82 - $100.00
Previous Close$9.03
Volume10.00
Average Volume (3M)1.01K
Market CapN/A
Enterprise ValueN/A
P/E Ratio-20.8
Beta-1.10
Next EarningsAug 24, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart ScoreN/A


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

CLLKF FAQ

What was BICO Group AB Class B’s price range in the past 12 months?
BICO Group AB Class B lowest stock price was $7.82 and its highest was $100.00 in the past 12 months.
    What is BICO Group AB Class B’s market cap?
    Currently, no data Available
    What is BICO Group AB Class B’s price target?
    Currently, no data Available
    What do analysts say about BICO Group AB Class B?
    Not enough analysts have published a price target to provide an average price target.
    When is BICO Group AB Class B’s upcoming earnings report date?
    BICO Group AB Class B’s upcoming earnings report date is Aug 24, 2022 which is in 48 days.
      How were BICO Group AB Class B’s earnings last quarter?
      BICO Group AB Class B released its earnings results on May 18, 2022. The company reported -$0.067 earnings per share for the quarter, beating the consensus estimate of -$0.155 by $0.089.
        Is BICO Group AB Class B overvalued?
        According to Wall Street analysts BICO Group AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does BICO Group AB Class B pay dividends?
          BICO Group AB Class B does not currently pay dividends.
          What is BICO Group AB Class B’s EPS estimate?
          BICO Group AB Class B’s EPS estimate is -$0.06.
            How many shares outstanding does BICO Group AB Class B have?
            BICO Group AB Class B has 62,586,270 shares outstanding.
              What happened to BICO Group AB Class B’s price movement after its last earnings report?
              BICO Group AB Class B reported an EPS of -$0.067 in its last earnings report, beating expectations of -$0.155. Following the earnings report the stock price went down -10.762%.
                Which hedge fund is a major shareholder of BICO Group AB Class B?
                Currently, no hedge funds are holding shares in CLLKF

                ---

                BICO Group AB Class B Stock Analysis

                Smart Score
                N/A
                Not Ranked
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                Price Target
                No data currently available
                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                BICO Group AB Class B

                CELLINK AB is engaged in the development and commercialization of bioprinting technologies. Its products allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products and for clinical applications. The company's technology is used to print tissues such as liver, cartilage, skin, and even fully functional cancer tumors that can then be used to develop new cancer treatments.

                ---
                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis